Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 3/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31037697 | 1.00 | TP53 (0.36) | TP53ABCG2MEN1RAB9AKMT2A | |
| SCHEMBL23855892 | 0.91 | ABCG2 (0.33) | TP53ABCG2MEN1RAB9AKMT2A | |
| SCHEMBL31037710 | 0.91 | ABCG2 (0.33) | TP53ABCG2MEN1RAB9AKMT2A | |
| SCHEMBL31037685 | 0.88 | MAPT (0.33) | TP53ABCG2MEN1RAB9AKMT2A | |
| SCHEMBL23855833 | 0.88 | MAPT (0.33) | TP53ABCG2MEN1RAB9AKMT2A | |
| SCHEMBL23855907 | 0.87 | ABCG2 (0.35) | TP53ABCG2MEN1RAB9AKMT2A | |
| SCHEMBL23855959 | 0.86 | TP53 (0.40) | TP53ABCG2MEN1RAB9AKMT2A | |
| SCHEMBL31037673 | 0.85 | L3MBTL1 (0.33) | TP53MEN1RAB9AKMT2AALDH1A1 | |
| SCHEMBL23855910 | 0.85 | L3MBTL1 (0.33) | TP53MEN1RAB9AKMT2AALDH1A1 | |
| SCHEMBL23855975 | 0.83 | ABCG2 (0.35) | TP53ABCG2MEN1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12029116-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2024-07-02 | — | — | US | disclosed |
| US-20210305517-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2021-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12029116-B2 | Composition of matter for use in organic light-emitting diodes | OPRD1, DRD1, DRD3 | TP53 4378/4885ABCG2 2195/4885MEN1 3613/4885 |
| US-20210305517-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | OPRD1, DRD1, DRD3 | TP53 4378/4885ABCG2 2195/4885MEN1 3613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.